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Interleukin-13 gene polymorphisms at -1055 C/T and +2044 G/A 
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Squamous cell carcinoma (SCC) is the most common malignancy that involves the upper aerodi-
gestive tract. Interleukin-13 (IL-13) is an immunoregulatory cytokine that has been reported to 
have some polymorphisms in it gene associated with same disease especially asthma and allergy. 
The present study aimed to investigate whether the polymorphisms of IL-13 gene (at positions of 
1055C/T in the promoter of1L-13 gene and +2044G/T exon-4) differ in patients with head and neck 
SCC from healthy controls.
Methods: This study was investigated in patient with head and neck SCC (n = 137) and age- and 
sex-matched healthy controls (n = 127). Genotyping of IL-13 gene polymorphism was performed 
using polymerase chain reaction-based restriction fragment length polymorphism method.
Results: No statistically significant differences were found in the frequencies of genotypes and al-
leles between patients and control group at both sites (p = 0.16). In addition, no association was 
observed between investigated genotypes and other potential prognostic factors such as age, sex, 
primary tumor site, tumor size and smoking.
Conclusion: This study suggests that there is no association between IL-13 gene polymorphisms 
(at position -1055C/T and +2044GI A) and susceptibility of the patients to SCC of head and neck.
ORIGINAL ARTICLE
Braz J Otorhinolaryngol.
2012;78(5):64-8. BJORL
Keywords:
carcinoma,
genetic,
head and neck 
neoplasms,
il-13,
polymorphism,
squamous cell.
.org
78(5) - inglês.indb   64 17/10/2012   15:04:05
65
Brazilian Journal of otorhinolaryngology 78 (5) SeptemBer/octoBer 2012
http://www.bjorl.org  /  e-mail: revista@aborlccf.org.br
INTRODUCTION
Cancer is a complex genetic disease derived from 
the accumulation of various genetic changes. Head 
and neck squamous cell carcinoma (HNSCC) is the 
most common malignancy of the aerodigestive tract 
and it accounts for more than 90% of malignancies in 
this area, with 500,000 new cases word wide1. It is the 
fifth leading cause of cancer incidence and sixth lead-
ing cause of cancer-related deaths despite significant 
improvement in conventional therapies. The overall 
survival for patients with HNSCC remained poor in 
past 30 years2. HNSCC affects more men than women 
and the most important independently risk factors are 
tobacco and alcohol1, although susceptibility (immuno-
logic factors and age), environmental and occupational 
factors may also play a role. Genetic predisposition to 
SCC is well recognized. Deletion, allelic imbalances or 
loss of heterozygosity on the short arm of chromosome 
3 has been associated with a more aggressive biologic 
behavior3. SCC of the head and neck is associated with 
production of pro-inflammatory and proangiogenic 
cytokines. In vitro analysis of cell lines derived from 
HNSCC and in situ studies of the local head and neck 
tumor microenvironment have demonstrated that head 
and neck tumors express a number of autocrine and 
paracrine growth factors and cytokines4.
The human IL-13 gene is together with the IL-4 
gene located within 15 kb on chromosome 5q315. IL-4 
and IL-13 share many (but not all) functions. To date, 
variation screening has been extensively performed 
for these genes and several single-nucleotide polymor-
phisms (SNPs) have been found to show functional 
significance and to be strongly associated with immune-
related disease. Recently, six novel polymorphisms 
have been described for the IL-13 locus including a 
polymorphism in exon 4 (+2044G/A) leading to an 
amino acid substitution at position 130 (Arg130Gln), 
the Gln form is strongly associated with increased se-
rum IgE levels in American and German populations6. 
Another polymorphism is located in promoter region 
of IL-13 gene (-1055 C/T) which is altered regulation 
of IL-13 production and increased binding of nuclear 
proteins7. The present study aimed to investigate as-
sociation of polymorphisms of IL-13 gene (at positions 
of 1055C/T in the promoter of1L-13 gene and +2044G/T 
exon-4) in patients with HNSCC.
Table 1. Patients’ characteristics.
Mean age (years)
Cancer patients 57.7 (14-81)
Healthy controls 57.1 (15-80)
Male/Female ratio
Cancer patients 115/22
Healthy controls 107/20
Primary site
Larynx 75
Tongue 24
Sinonasal tract 13
Oral cavity 10
Hypopharynx 6
Lip 4
Oropharynx 3
Nasopharynx 2
METHOD
A group of 137 patients (mean age of 57.7 years) 
with head and neck SCC (115 male and 22 female) were 
recruited in this study and been compared with 127 
age- and sex-matched healthy controls (mean age of 
57.1 years) whom none had history of cancer and auto-
immune disease in their first degree relatives. (Table 1).
DNA preparation
DNA was extracted from peripheral blood sam-
ples using the traditional Proteinase-K method. Then 
DNA was prepared in 300 ng/µl concentration.
Genotyping assay
Genotyping at both position +2044 and -1055 
of IL13 were studied using polymerase chain reaction 
(PCR)-based restriction fragment length polymorphism 
method. To evaluate the 1055C/T position, the primer 
sequences of 5’ -ACTTCTGGGAGTCAGAGCCA-3’ 
(forward); and 5’-TACAGCCATGTCGCCTTTTCCTGC-
TCTTCCGTC-3’ (reverse) were used. PCR was carried 
out in a volume of 15 µl containing 75 ng of genomic 
DNA, 1.5 mM KCL buffer lX, 1.5 mM MgC12, 0.3 mM 
dNTPs, 3 pm each primer and 1.2 unit of Taq DNA 
polymerase. The DNA was first denatured at 94°C for 
5 min, then the cycling temperature was set at 94°C for 
30 seconds as the first denaturation cycle, 65.5°C for 30 
seconds as the annealing cycle, 72°C for 30 seconds as 
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the extension cycle, all repeating for a total 30 cycles, 
followed by a final extension at 72°C for 10 min. 5 µl 
of PCR products were electrophoresed on 1.5% agarose 
gels and visualized with ethidiom bromide staining and 
Gene documentation. Enzyme digestion was carried 
out in a 15 µl final volume using 0.5 µl “Hpy199I” 
enzyme, 1.5 µl NTB4 buffer, 0.15 µl BSA buffer, 2.85 
µl H20 and 10 µl of PCR product. The reactions were 
incubated at 37°C for 2 hours. The sizes of corres-
ponding fragments were: CC = 339, 33 bp, CT = 372, 
339, 33 bp and TT = 372 bp. Finally, the digested PCR 
products were electrophoresed on 2.7% agarose gels 
to separate the fragments The assay conditions for the 
polymorphism at +2044G/A was as following: forward 
primer: 5’-CTTCCGTGAGGACTGAATGAGACGGTC-3’ 
and reverse primer: 5’-GCAAATAATGATGCTTTCGA-
AGTTTCAGTGGA-3’, each was used for a total of 6 pm 
per a tube. The “NlaIV” restriction enzyme was used 
to digest 236 bp fragment and produce GG = 178, 32, 
26 bp, GA = 216, 178, 32, 26 bp and AA = 216, 26 bp 
fragments. The optimal annealing temperature for this 
test was 62.5°C.
Statistical analysis
Allele and genotype frequencies and quantitative 
traits were compared between control and patients’ 
subtypes by the use of Chi-square (χ2) and Fisher exact 
tests. The results were then scheduled by SPSS 15 and 
EPI info (version 2002) soft wares and the associations 
were analyzed to adjust for different respective factors. 
P-values more than 0.05 were considered insignificant.
Table 2. Allele and Genotype frequencies at -1055C/T and +2044 G/A positions in IL-13.
Subjects -1055C/T +2044G/A
Genotype CC CT TT C allele T allele GG GA AA G allele A allele
Patient (n = 137)
86 41 7 211 59 73 56 8 200 72
(62%) (30%) (8%) (78%) (22%) (53%) (41%) (6%) (74% (26%)
Control (n = 127)
61 48 8 171 67 53 51 13 157 79
(48%) (37%) (15%) (72%) (17%) (42%) (41%) (17%) (67%) (33%)
p-value 0.16 0.1 0.17 0.08
Table 3. Genotype distribution at -1055C/T and +2044 G/A positions in IL-13 among patients with HNSCC and healthy controls.
Subjects CC+GG CC=GA CC+AA CT+GG CT+GA CT+AA TT+GG TT+GA TT+AA
Patient (n = 137)
52 30 3 17 24 3 3 2 2
(38%) (22%) (2%) (13%) (18%) (2%) (2%) (1.5%) (1.5%)
Control (n = 127)
34 20 4 15 28 6 3 3 3
(27%) (16%) (3%) (12%) (22%) (5%) (2%) (2%) (2%)
p-value 0.62
This study was approved by the Ethics Commit-
tee of the institution.
RESULTS
IL-13, -1055 and +2044 genotypes and alleles
As depicted in Table 2, screening of the patients 
for the IL-13 genotype and allele frequencies of the 
C-l055T and G+2044A polymorphisms revealed no 
significant differences in these two genotypes and their 
alleles in patients with HNSCC compared to healthy 
controls. Different genotypes of both sites were also 
collated two by two to evaluate any combination 
through them. According to the data depicted in Table 
3, no linkage was identified within either of 137 patients 
and 127 control subjects.
IL-13 -1055 and +2044 genotypes and head and neck 
predisposing factors
Genotypes and alleles harvested from the two 
polymorphisms were investigated in order to achieve 
any association with patients’ baseline values like age 
and gender or prognostic/predictive factors such as 
primary tumor site, tumor size and smoking. Although, 
HNSCC is consistently attributed to each of them, no 
association was observed regarding these two poly-
morphism substitutions.
DISCUSSION
Cancer genes are generally grouped into on-
cogenes and tumor suppressor genes. Neoplastic dis-
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eases are complex genetic disorder that results from 
imbalance between activation of proto-oncogenes and 
inactivation of tumor suppressor genes. The human 
genome project currently offers a unique opportunity 
for identification of all the genetic changes associated 
with a human cancer8. Cytokines and related genes can 
directly or indirectly act against defense mechanisms of 
tumor with changes in type of immune response and 
its quality2. T helper immune responses or cytotoxic 
T cell activation are essential for antitumor actions. 
Several studies with animal model and human patients 
with cancer revealed that in these cases conventional 
responses of Th1 and activities of CD8+ cells were in-
hibited. The tendency of antitumor immune responses 
to Th2 leads to suppression of Th1 responses9,l0. In a 
study, the expression of Th1 and Th2 cytokines was 
evaluated in human tumoral cells that revealed domi-
nancy of type II cytokines in 20 types of tumor cells. 
The escape of tumor cells from immune control may 
be related to this phenomenon10.
In other studies, the investigators observed that 
IL-4 and IL-13 can inhibit the tumor regression11. In 
another study, The effects of human IL-4 and IL-13 on 
clonal growth of breast cancer cells were investigated 
that revealed IL-13 can reduced clonal growth of 3 
cell type7. These studies concluded that IL-13 have 
important role in regulation of antitumor activities. 
There were several polymorphisms in IL-13 gene. The 
1055C/T was located in promoter region of IL-13 gene. 
The change of C to T nucleotide in this point may alter 
attachment and transcription factor type and then alter 
the expression of IL-13 gene. Several studies revealed 
that -1055C/T polymorphism was associated with al-
lergic asthma, altered regulation of IL-13 production 
and increased binding of nuclear protein12.
Another important polymorphism in IL-13 gene is 
+2044 G/A that is located on Exon-4 that is important 
region for receptor-ligand interaction. Replacement of 
Arginin to Glutamine (Arg130G1n) leads to creation of 
an IL-13 protein with high affinity to its receptor. This 
can explain theoretically many aspects of allergic phe-
notype (IgE production, mucus secretion, eosinophilic 
inflammation and hyper sensitivity reaction)9. This allele 
was associated with increased susceptibility of diabetes 
type 1 and COPD and its frequency was low in patients 
with Juvenile idiopathic arthritis and graves disease3. In 
our study the 1055C/T and +2044G/A polymorphisms 
was analyzed in patients with head and neck SCC. 
Previous study has been carried out on patients with 
head and neck SCC.
In the literature, there are few studies investigat-
ing the association of IL-13 haplotypes and susceptibil-
ity to cancers. Faghih et al.13 investigated the associa-
tion of IL-13 haplotypes and susceptibility of Iranian 
women to breast cancer. They found no significant 
differences in the distribution of -1512A/C, -1055C/T 
and +2044G/A genotypes or alleles between patients 
and the control group; however, they suggested a 
potential association of CCA haplotype of IL13 gene 
with susceptibility of Iranian women to breast cancer. 
In another study, Sameni et al.14 found no association 
between interleukin-13 gene polymorphisms (-1055 C/T 
and +2044 G/A) in Iranian patients with lung cancer. 
To the best of our knowledge, this is the first study 
investigating IL-13 gene polymorphisms at -1055 C/T 
and +2044 G/A positions in patients with squamous 
cell carcinoma of head and neck.
CONCLUSION
Results of this study indicate no association be-
tween IL-13 gene polymorphisms (at position -1055C/T 
and +2044G/A) and susceptibility of the patients to 
HNSCC.
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